Can Yervoy Discounts Apply Retroactively to Past Treatments?
No, Yervoy (ipilimumab) discounts from Bristol Myers Squibb's patient assistance programs, copay cards, or commercial savings offers do not cover past treatments. These programs require enrollment before or at the time of treatment initiation, with reimbursement limited to future eligible fills or infusions.[1]
How Yervoy Patient Assistance Programs Work
Bristol Myers Squibb's Access Support program offers free or discounted Yervoy for uninsured or underinsured patients meeting income criteria (typically up to 500% of federal poverty level). Applications must be submitted prior to treatment, and approval covers ongoing therapy only—no retroactive claims for prior doses.[2] Commercial copay assistance caps out-of-pocket costs at $0-$5 per dose for eligible insured patients but activates only on current or future prescriptions.
What About Copay Cards or Savings Cards?
Yervoy Savings Card (via BMS or platforms like GoodRx) reduces copays instantly at the pharmacy or infusion center but applies solely to the date-of-service transaction. Pharmacies and providers do not process retroactive adjustments for past bills under these cards, as they function as point-of-sale discounts.[3]
Alternatives for Covering Past Treatment Costs
- Appeals to Insurers: If denial was due to prior authorization issues, patients can request retroactive coverage via appeals, but this is insurance-specific—not tied to Yervoy discounts.
- Manufacturer Compassionate Use: Rare cases of post-treatment hardship grants exist, but require direct contact with BMS Access Support (1-888-423-5227); success is low for fully past treatments.
- Non-Profit Aid: Organizations like Patient Access Network (PAN) or CancerCare may reimburse recent uninsured costs, with eligibility windows up to 90 days post-treatment.[4]
Common Patient Questions on Yervoy Affordability
Patients often ask about stacking discounts (not allowed) or state assistance integration. Uninsured cash prices for a Yervoy infusion course exceed $150,000, driving 70% of eligible patients to BMS programs annually.[1][2]
Sources:
[1]: Bristol Myers Squibb Access Support
[2]: Yervoy Patient Assistance Application
[3]: GoodRx Yervoy Pricing
[4]: Patient Access Network Foundation